Skip to main content
. 2020 Dec 31;13(1):110. doi: 10.3390/cancers13010110
BC Breast Cancer
TILs tumor infiltrating lymphocytes
DCs dendritic cells
Tregs CD4+ regulatory T cells
CIC cancer-immunity cycle
TIME tumor immune microenvironment
CYT immune cytolytic activity
TCGA The Cancer Genome Atlas
METABRIC Molecular Taxonomy of Breast Cancer International Consortium
TN triple negative
ER estrogen receptor
PgR progesterone receptor
HR hormone receptor
TMB tumor mutation burden
SNV single-nucleotide variant
IFN interferon
GSEA Gene Set Enrichment Analyses
NES normalized enrichment score
FDR false discovery rate
OS overall survival
HER2 human epidermal growth factor receptor 2
PFS progression free survival
BCSS breast cancer specific survival
NCI National Cancer Institute
TPM Transcripts Per Million
RFS recurrence-free survival